Epsilon Healthcare Limited
HDRPF
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.73M
Close$
Share Statistics
| Market cap | $9.73 Million |
|---|---|
| Enterprise Value | $17.12 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | 0.75 |
| Outstanding Shares | 389,104,011 |
Return
| Return on Equity | -16.89% |
|---|---|
| Return on Assets | -3.36% |
| Return on Invested Capital | -13.18% |
Valuation & Multiples
| P/E Ratio | 83.33 |
|---|---|
| PEG | -125.93 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.85 |
| Enterprise Value to EBIT | -9.57 |
| Enterprise Value to Net Income | -27 |
| Total Debt to Enterprise | 0.51 |
| Debt to Equity | 2.24 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Epsilon Healthcare Limited
14 employees
CEO: Peter Giannopoulos Epsilon Healthcare Limited operates as an Australian-based healthcare and pharmaceutical firm, with significant operations also extending into Canada. Established in 2016 and headquartered in Sydney, the company specializes in several ar...